Genmab A/S
BISPECIFIC ANTIBODIES AGAINST HER2 AND CD3
Last updated:
Abstract:
Bispecific antibodies which comprise one antigen-binding region binding to an epitope of human epidermal growth factor receptor 2 (HER2) and one antigen-binding region binding to human CD3, and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and methods for preparing and using the antibodies are also disclosed.
Status:
Application
Type:
Utility
Filling date:
29 Oct 2019
Issue date:
27 Aug 2020